Leadership Transition - David McCreight was announced as Interim President & CEO, and Thomas Folliard as Interim Executive Chair, effective December 1, 2025[6] - Former Chief Executive Officer, Bill Nash, stepped down from his position and as a member of the Board effective December 1, 2025[9] Q3 2026 Financial Performance - Net earnings per share decreased by 24.7% year-over-year to $0.64[24, 27] - Total gross profit decreased by 12.9% year-over-year to $590.0 million[24] - SG&A expense increased by 1.0% year-over-year to $581.4 million[24] - CarMax Auto Finance (CAF) income increased by 9.3% year-over-year to $174.7 million[27] Sales Performance - Total vehicles bought decreased by 11.7% year-over-year to 238,000 units[24] - Retail used unit sales decreased by 6.2% year-over-year[24] - Wholesale unit sales decreased by 9.0% year-over-year[24] Capital Allocation - The company repurchased $201.6 million in shares of common stock[17]

Financial Performance - CarMax reported earnings per share of $1.38, exceeding the analyst consensus estimate of $1.21 [1] - Quarterly sales reached $7.55 billion, surpassing the analyst consensus estimate of $7.47 billion [1] Business Expansion - The company opened two new stand-alone reconditioning/auction centers in El Mirage, Arizona, and Midlothian, Texas [2] Management Commentary - CEO Bill Nash highlighted the fourth consecutive quarter of positive retail comps and double-digit year-over-year earnings per share growth, emphasizing the strength of the company's earnings growth model [3] - Nash noted the importance of the omni-channel experience and the integration of associates, stores, technology, and digital capabilities in enhancing customer experience [3] Analyst Ratings and Price Targets - Truist Securities maintained a Hold rating and raised the price target from $72 to $74 [6] - RBC Capital maintained an Outperform rating and increased the price target from $80 to $81 [6] - Needham reiterated a Buy rating with a price target of $92 [6]

As filed with the Securities and Exchange Commission on September 27, 2024. Registration No. 333-280945 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Danam Health, Inc. (Exact name of registrant as specified in its charter.) (State or other jurisdiction of incorporation or organization) Delaware 8090 93-3264234 (Primary Standard Industrial Classification Number) (IRS Employer Identification No.) 300 ...